EPIVIR
- Product NDC
- 0173-0663
- 11-digit product format
- 001730663
- Labeler code
- 0173
- Product ID
- 0173-0663_9a79fee6-b801-4f7d-b140-1eed51338a6e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lamivudine
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- GlaxoSmithKline LLC
- Application
- NDA021004
- Marketing category
- NDA
- Marketing start
- 1998-12-23
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0173-0663-00 | 00173066300 | 240 mL in 1 BOTTLE (0173-0663-00) | 240 ml | 1998-12-23 | 0000-00-00 | No | No | Current |